Opportunity ID: 335141

General Information

Document Type: Grants Notice
Funding Opportunity Number: RFA-NS-22-001
Funding Opportunity Title: Biomarkers for the Lewy Body Dementias (U01 Clinical Trial Not Allowed)
Opportunity Category: Discretionary
Opportunity Category Explanation:
Funding Instrument Type: Cooperative Agreement
Category of Funding Activity: Health
Category Explanation:
Expected Number of Awards:
Assistance Listings: 93.853 — Extramural Research Programs in the Neurosciences and Neurological Disorders
Cost Sharing or Matching Requirement: No
Version: Synopsis 1
Posted Date: Aug 06, 2021
Last Updated Date: Aug 06, 2021
Original Closing Date for Applications: Nov 22, 2021
Current Closing Date for Applications: Nov 22, 2021
Archive Date: Dec 28, 2021
Estimated Total Program Funding:
Award Ceiling:
Award Floor:

Eligibility

Eligible Applicants: County governments
Native American tribal governments (Federally recognized)
State governments
Native American tribal organizations (other than Federally recognized tribal governments)
Others (see text field entitled “Additional Information on Eligibility” for clarification)
Independent school districts
Public housing authorities/Indian housing authorities
Public and State controlled institutions of higher education
For profit organizations other than small businesses
Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education
Special district governments
City or township governments
Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education
Private institutions of higher education
Small businesses
Additional Information on Eligibility: Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession; Non-domestic (non-U.S.) Entities (Foreign Institutions) are not eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, are allowed.

Additional Information

Agency Name: National Institutes of Health
Description: The purpose of this funding opportunity announcement (FOA) is to support hypothesis-driven clinical research applications that are focused on discovering novel diagnostic, prognostic, and/or therapeutic biomarkers for the Lewy Body Dementias (LBD).Biomarker research must be conducted in patients with LBD, must follow Parkinson’s Disease Biomarker Program (PDBP) protocols for clinical assessment and biospecimen collection,and must be broadly shareable through the PDBP repositories.
Link to Additional Information: http://grants.nih.gov/grants/guide/rfa-files/RFA-NS-22-001.html
Grantor Contact Information: If you have difficulty accessing the full announcement electronically, please contact:

NIH OER Webmaster
OERWebmaster03@od.nih.gov
Email:OERWebmaster03@od.nih.gov

Version History

Version Modification Description Updated Date

Related Documents

Packages

Agency Contact Information: NIH OER Webmaster
OERWebmaster03@od.nih.gov
Email: OERWebmaster03@od.nih.gov
Who Can Apply: Organization Applicants

Assistance Listing Number Competition ID Competition Title Opportunity Package ID Opening Date Closing Date Actions
FORMS-F Use for due dates on or before January 24, 2022 PKG00268469 Sep 22, 2021 Jan 24, 2022 View
FORMS-G Use for due dates on or after January 25, 2022 PKG00270439 Nov 18, 2021 Nov 22, 2021 View

Package 1

Mandatory forms

335141 RR_SF424_2_0-2.0.pdf

335141 PHS398_CoverPageSupplement_5_0-5.0.pdf

335141 RR_OtherProjectInfo_1_4-1.4.pdf

335141 PerformanceSite_2_0-2.0.pdf

335141 RR_KeyPersonExpanded_2_0-2.0.pdf

335141 PHS398_ResearchPlan_4_0-4.0.pdf

335141 PHSHumanSubjectsAndClinicalTrialsInfo_2_0-2.0.pdf

Optional forms

335141 RR_Budget_1_4-1.4.pdf

335141 RR_SubawardBudget30_1_4-1.4.pdf

335141 PHS398_ModularBudget_1_2-1.2.pdf

335141 PHS_AssignmentRequestForm_3_0-3.0.pdf

Package 2

Mandatory forms

335141 RR_SF424_5_0-5.0.pdf

335141 PHS398_CoverPageSupplement_5_0-5.0.pdf

335141 RR_OtherProjectInfo_1_4-1.4.pdf

335141 PerformanceSite_4_0-4.0.pdf

335141 RR_KeyPersonExpanded_4_0-4.0.pdf

335141 PHS398_ResearchPlan_4_0-4.0.pdf

335141 PHSHumanSubjectsAndClinicalTrialsInfo_3_0-3.0.pdf

Optional forms

335141 RR_Budget_3_0-3.0.pdf

335141 RR_SubawardBudget30_3_0-3.0.pdf

335141 PHS398_ModularBudget_1_2-1.2.pdf

335141 PHS_AssignmentRequestForm_3_0-3.0.pdf

2025-07-11T16:38:42-05:00

Share This Post, Choose Your Platform!

About the Author: